199 related articles for article (PubMed ID: 28079011)
21. Natural Bioactive Compounds as Emerging Therapeutic Molecules Against Breast Cancer: Emphasis on the Role of Phytoestrogens.
Malayil AS; Poothaadammal AK; Narayanankutty A
Curr Drug Targets; 2021; 22(11):1255-1271. PubMed ID: 33172378
[TBL] [Abstract][Full Text] [Related]
22. Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells.
Cappelletti V; Miodini P; Di Fronzo G; Daidone MG
Int J Oncol; 2006 May; 28(5):1185-91. PubMed ID: 16596234
[TBL] [Abstract][Full Text] [Related]
23. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
24. Phytoestrogens and their effects.
Sirotkin AV; Harrath AH
Eur J Pharmacol; 2014 Oct; 741():230-6. PubMed ID: 25160742
[TBL] [Abstract][Full Text] [Related]
25. Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.
Bak MJ; Das Gupta S; Wahler J; Suh N
Semin Cancer Biol; 2016 Oct; 40-41():170-191. PubMed ID: 27016037
[TBL] [Abstract][Full Text] [Related]
26. Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitro.
Limer JL; Parkes AT; Speirs V
Int J Cancer; 2006 Aug; 119(3):515-21. PubMed ID: 16506217
[TBL] [Abstract][Full Text] [Related]
27. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
Zava DT; Duwe G
Nutr Cancer; 1997; 27(1):31-40. PubMed ID: 8970179
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the safety profiles of estrogenic Chinese herbal medicines in breast cancer.
Yue GG; Wong LS; Leung HW; Gao S; Tsang JY; Lin ZX; Tse GM; Lau CB
Phytomedicine; 2019 Mar; 56():103-117. PubMed ID: 30668331
[TBL] [Abstract][Full Text] [Related]
29. Phytoestrogens, novel dietary supplements for breast cancer.
Huang S; Qi B; Yang L; Wang X; Huang J; Zhao Y; Hu Y; Xiao W
Biomed Pharmacother; 2023 Apr; 160():114341. PubMed ID: 36753952
[TBL] [Abstract][Full Text] [Related]
30. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.
Hirsch K; Atzmon A; Danilenko M; Levy J; Sharoni Y
Breast Cancer Res Treat; 2007 Aug; 104(2):221-30. PubMed ID: 17051425
[TBL] [Abstract][Full Text] [Related]
31. Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells.
Seo HS; Choi HS; Choi HS; Choi YK; Um JY; Choi I; Shin YC; Ko SG
Anticancer Res; 2011 Oct; 31(10):3301-13. PubMed ID: 21965740
[TBL] [Abstract][Full Text] [Related]
32. Phytoestrogens in menopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model.
van Duursen MB; Smeets EE; Rijk JC; Nijmeijer SM; van den Berg M
Toxicol Appl Pharmacol; 2013 Jun; 269(2):132-40. PubMed ID: 23541764
[TBL] [Abstract][Full Text] [Related]
33. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
[TBL] [Abstract][Full Text] [Related]
34. The Potential Effects of Phytoestrogens: The Role in Neuroprotection.
Gorzkiewicz J; Bartosz G; Sadowska-Bartosz I
Molecules; 2021 May; 26(10):. PubMed ID: 34065647
[TBL] [Abstract][Full Text] [Related]
35. Flavonoid effects relevant to cancer.
Brownson DM; Azios NG; Fuqua BK; Dharmawardhane SF; Mabry TJ
J Nutr; 2002 Nov; 132(11 Suppl):3482S-3489S. PubMed ID: 12421874
[TBL] [Abstract][Full Text] [Related]
36. Phytoestrogens oestrogen synthesis and breast cancer.
Rice S; Whitehead SA
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):186-95. PubMed ID: 17936616
[TBL] [Abstract][Full Text] [Related]
37. Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways.
Saggar JK; Chen J; Corey P; Thompson LU
Mol Nutr Food Res; 2010 Mar; 54(3):415-25. PubMed ID: 19904759
[TBL] [Abstract][Full Text] [Related]
38. Cyclopeptide RA-V inhibits cell adhesion and invasion in both estrogen receptor positive and negative breast cancer cells via PI3K/AKT and NF-κB signaling pathways.
Leung HW; Wang Z; Yue GG; Zhao SM; Lee JK; Fung KP; Leung PC; Lau CB; Tan NH
Biochim Biophys Acta; 2015 Aug; 1853(8):1827-40. PubMed ID: 25953046
[TBL] [Abstract][Full Text] [Related]
39. Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines.
Dagdemir A; Durif J; Ngollo M; Bignon YJ; Bernard-Gallon D
Epigenomics; 2013 Feb; 5(1):51-63. PubMed ID: 23414320
[TBL] [Abstract][Full Text] [Related]
40. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
Collins-Burow BM; Burow ME; Duong BN; McLachlan JA
Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
